Protein synthesis levels are increased in a subset of individuals with fragile X syndrome

Affiliations

• ¹ Sainte-Justine University Hospital Research Centre, Montreal, QC H3T 1C5.
• ² University of Montreal, Montreal, QC H3T 1J4, Canada.
• ³ Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
• ⁴ Department of Clinical Genetics, Odense University Hospital.
• ⁵ Human Genetics, Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark.
• ⁶ Neuroscience Translational Medicine, Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
• ⁷ Biomarker Development, Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
• ⁸ Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California, Davis Medical Center, Sacramento, CA, USA.
• ⁹ Department of Clinical Genetics, Erasmus Medical Center, DRRotterdam, Netherlands.
• ¹⁰ Neuroscience Discovery, Novartis Institutes for BioMedical Research, Basel, Switzerland.
• ¹¹ Department of Biochemistry and Molecular Medicine and Medical Investigation of Neurodevelopmental Disorders (MIND) Institute.
• ¹² Department of Pediatric and Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis, School of Medicine, Sacramento, CA, USA.
• ¹³ Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
• ¹⁴ Department of Fundamental Neuroscience, University of Lausanne, Lausanne, Switzerland.